On 18th and 19th December 2018 the 7th General Assembly and 4th Investigators meeting of NeoVanc project will take place in Athens, Greece.
Hosted by PENTA partner
CLEO, the gathering will chiefly focus on consolidating the milestone achievement of having enrolled
more than 180 patients. Other important items to be discussed on the agenda include a PK Update, SAEs reporting/Safety, and Future neonatal sepsis trials.
The team will also work together to promote further actions towards a successful outcome to this interesting and meaningful project.
Funded by the European Commission’s FP7 programme,
NeoVanc involves 12 European partners and is coordinated by PENTA.